Avantor (AVTR) Stock
Key stats
- Market cap
- $10.66B
- Price / Earnings ratio
- 31.3x
- EPS (TTM)
- $0.50
- Volume
- Loading
- 52-week high
- $17.45
- 52-week low
- $7.27
- EPS vs analyst estimate
- -4.3%Q3 FY25 · $0.22 vs $0.23
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with AVTR
Recent news

Avantor (AVTR) Upgraded to Buy: What Does It Mean for the Stock?
Avantor (AVTR) Upgraded to Buy: What Does It Mean for the Stock?
AVTR

Avantor, Inc. (AVTR) is a Great Momentum Stock: Should You Buy?
Avantor, Inc. (AVTR) is a Great Momentum Stock: Should You Buy?
AVTR

Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
AVTR

What Avantor (AVTR) Said on Its Q3 Earnings Call
What Avantor (AVTR) Said on Its Q3 Earnings Call
AVTR
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 47.87
- MACD 12/26/9
- -0.03
- EMA 9 of MACD
- 0.12
- MACD histogram
- -0.15
- SMA 50
- $15.67
- Price above SMA 50
- EMA 50
- $15.42
- Price above EMA 50
- SMA 200
- $11.34
- Price above SMA 200
- EMA 200
- $12.46
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 6 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.23 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Avantor (AVTR) Upgraded to Buy: What Does It Mean for the Stock?
Avantor (AVTR) Upgraded to Buy: What Does It Mean for the Stock?
AVTR

Avantor, Inc. (AVTR) is a Great Momentum Stock: Should You Buy?
Avantor, Inc. (AVTR) is a Great Momentum Stock: Should You Buy?
AVTR

Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
AVTR

What Avantor (AVTR) Said on Its Q3 Earnings Call
What Avantor (AVTR) Said on Its Q3 Earnings Call
AVTR

Avantor, Inc. (AVTR) Surpasses Q3 Earnings and Revenue Estimates
Avantor, Inc. (AVTR) Surpasses Q3 Earnings and Revenue Estimates
AVTR

Here's Why You Should Add Avantor Stock to Your Portfolio for Now
Here's Why You Should Add Avantor Stock to Your Portfolio for Now
AVTR

VTRS vs. AVTR: Which Stock Is the Better Value Option?
VTRS vs. AVTR: Which Stock Is the Better Value Option?
AVTR

Are Medical Stocks Lagging Avantor (AVTR) This Year?
Are Medical Stocks Lagging Avantor (AVTR) This Year?
AVTR

Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC
AVTR

Here's Why You Should Add Avantor Stock to Your Portfolio for Now
Here's Why You Should Add Avantor Stock to Your Portfolio for Now
AVTR
News tone: automated (AI) classification of the article's content, not a price prediction.
About Avantor
Avantor is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Emmanuel Ligner | President, CEO & Director | 1971 |
| Mr. Todd W. Garner CPA | Executive VP & CFO | 1969 |
| Ms. Mary Blenn | Executive VP & COO | — |
| Mr. Claudius O. Sokenu | Executive VP, Corporate Secretary and Chief Legal & Compliance Officer | 1968 |
| Mr. Corey D. Walker | President of Laboratory Solutions | 1978 |
| Mr. Benoit Gourdier | Executive Vice President of Bioscience Production | 1967 |
| Mr. Steven W. Eck | Senior VP, Corporate Controller & Chief Accounting Officer | 1976 |
| Mr. Chris Fidyk | Vice President of Investor Relations | — |
| Ms. Brittany Hankamer | Executive VP & Chief Human Resources Officer | 1971 |
| Mr. Christophe Couturier M.B.A | Executive Vice President of AMEA | 1966 |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 47.87
- MACD 12/26/9
- -0.03
- EMA 9 of MACD
- 0.12
- MACD histogram
- -0.15
- SMA 50
- $15.67
- Price above SMA 50
- EMA 50
- $15.42
- Price above EMA 50
- SMA 200
- $11.34
- Price above SMA 200
- EMA 200
- $12.46
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
6 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $15.00
- Average
- $16.83
- High
- $18.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +2.6 | +10.1 | ||||||||||
| 2022 | -8.0 | -8.7 | -1.2 | -6.8 | +1.9 | -2.6 | -8.2 | -15.5 | -21.4 | -0.2 | +11.5 | -7.5 |
| 2023 | +12.9 | -0.2 | -13.9 | -6.2 | -1.4 | +3.2 | +1.2 | +3.6 | -2.9 | -16.4 | +21.7 | +6.8 |
| 2024 | +1.1 | +4.6 | +2.3 | -4.0 | -1.4 | -12.6 | +28.8 | -2.5 | +3.0 | -12.0 | -5.6 | -0.1 |
| 2025 | +5.1 | -23.6 | +2.1 | -17.8 | -0.4 | +3.9 | -3.4 | +18.6 | -6.1 | -13.5 | +0.4 | -2.5 |
| 2026 | -4.7 | -18.2 | -11.0 | +4.2 | +14.6 | +7.7 | +37.7 | +6.4 | +6.0 | +6.8 | +0.8 |




